MYH14
protein-codingmyosin heavy chain 14, the group of Myosin heavy chains, class II
Gene summary
This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
- DFNA4
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~122.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0010915
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013711
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0013711
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0013711
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0010915
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0019497
Submitter: ClinGen
The relationship between MYH14 and autosomal dominant nonsyndromic genetic deafness was described in 2004 by Donaudy et al. (PMID:15015131). At least 14 unique variants (missense, nonsense) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level, segregation, and experimental data. MYH14 is thought to play a beneficial role in the protection of the cochlea after acoustic over-stimulation and that loss of function leads to progressive hearing loss (PMID: 28101381). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This classification was approved by the ClinGen Hearing Loss Working Group on 8/31/2020. Of note, MYH14 has also been associated with a neuropathy phenotype that includes hearing loss, but that evidence was not included in this curation.
Inheritance Pattern: AD
Disease ID:MONDO:0010915
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0013711
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: The onset of deafness has been described as postlingual
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYH14 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001145809.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 251 | 14 | 296 | ||
| missense | 2 | 11 | 791 | 99 | 11 | 914 |
| nonsense | 6 | 1 | 7 | 14 | ||
| start loss | 1 | 1 | ||||
| frameshift | 9 | 6 | 9 | 1 | 25 | |
| splice donor/acceptor (+/-2bp) | 7 | 22 | 29 | |||
| Total | 17 | 25 | 861 | 351 | 25 | 1279 |
Highest pathogenic variant AF is 0.00003592461
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001139281.1 | 42 | MANE Select | |
| Ensembl | ENSP00000493594.1 | 42 | MANE Select | |
| RefSeq | NP_001070654.1 | 41 | Standard | |
| RefSeq | NP_079005.3 | 40 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Salmonella infection - Homo sapiens (human)
- Tight junction - Homo sapiens (human)
- Regulation of actin cytoskeleton - Homo sapiens (human)
- Developmental Biology
- Signal Transduction
Biological Process
- skeletal muscle contraction
- skeletal muscle tissue development
- sensory perception of sound
- regulation of cell shape
- neuronal action potential
Molecular Function
- microfilament motor activity
- calmodulin binding
- ATP binding
- ATPase activity
- actin-dependent ATPase activity
Cellular Component
- stress fiber
- cytosol
- brush border
- membrane
- myosin II complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000601313
- Coding exons
- 42
- Length
- 122360
- Individuals with no LoFs
- 125714
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 33
- Defined
- 125747
- p
- 0.000131
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.28 | 1069 | 1.30e+3 | 0.822 | 0.0000951 | 12845 |
| Missense (PolyPhen) | 381 | 501.56 | 0.75963 | 4787 | ||
| Synonymous | 1.87 | 476 | 531 | 0.897 | 0.0000352 | 4160 |
| Loss of Function | 7.46 | 27 | 112 | 0.241 | 0.00000620 | 1204 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00031 | 0.00030 | rare |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.000093 | 0.000092 | rare |
| European (Non-Finnish) | 0.00018 | 0.00018 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. {ECO:0000250}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 4A (DFNA4A) [MIM:600652]: A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. {ECO:0000269|PubMed:15015131, ECO:0000269|PubMed:16222661}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Peripheral neuropathy, myopathy, hoarseness, and hearing loss (PNMHH) [MIM:614369]: A complex phenotype of progressive peripheral neuropathy and distal myopathy, with later onset of hoarseness and hearing loss. Affected individuals develop distal muscle weakness at a mean age of 10.6 years, followed by progressive atrophy of these muscles. The lower limbs are more severely affected than the upper limbs, and the muscle weakness first affects anterior leg muscles and later posterior leg muscles. {ECO:0000269|PubMed:21480433}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- LoFtool
- 0.0292
- RVIS EVS
- -2.24
- RVIS percentile EVS
- 1.31
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.428
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |